Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
November 4, 2000
The A19G polymorphism in the 5' untranslated region of the human obese gene does not affect leptin levels in severely obese patients
R Lucantoni, E Ponti, M E Berselli, et al.
Journal of Endocrinological Investigation
|
October 1, 1980
Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states
G Verde, P G Chiodini, A Liuzzi, et al.
Journal of Endocrinological Investigation
|
February 1, 1984
Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment
G Verde, P Loli, M E Berselli, et al.
Clinical Endocrinology
|
January 1, 1980
Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride
P G Chiodini, A Liuzzi, G Verde, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
May 22, 2001
Contribution of weight cycling to serum leptin in human obesity
Z L Benini, M A Camilloni, C Scordato, et al.
International Journal of Obesity (2005)
|
February 13, 2013
Permanence of molecular features of obesity in subcutaneous adipose tissue of ex-obese subjects
R Cancello, A Zulian, D Gentilini, et al.
Journal of Molecular Endocrinology
|
December 1, 1995
A thyroid hormone receptor beta gene polymorphism associated with Graves' disease
V Tassi, L Scarnecchia, A Di Cerbo, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
October 18, 2000
Leptin plasma concentrations are dependent on body fat distribution in obese patients
A Minocci, G Savia, R Lucantoni, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1981
Size reduction of macroprolactinomas by bromocriptine or lisuride treatment
P Chiodini, A Liuzzi, R Cozzi, et al.
Journal of Endocrinological Investigation
|
April 9, 2002
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study
M Gasperi, E Martino, L Manetti, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
The Journal of Clinical Endocrinology and Metabolism
|
November 4, 2000
The A19G polymorphism in the 5' untranslated region of the human obese gene does not affect leptin levels in severely obese patients
R Lucantoni, E Ponti, M E Berselli, et al.
Journal of Endocrinological Investigation
|
October 1, 1980
Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states
G Verde, P G Chiodini, A Liuzzi, et al.
Journal of Endocrinological Investigation
|
February 1, 1984
Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment
G Verde, P Loli, M E Berselli, et al.
Clinical Endocrinology
|
January 1, 1980
Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride
P G Chiodini, A Liuzzi, G Verde, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
May 22, 2001
Contribution of weight cycling to serum leptin in human obesity
Z L Benini, M A Camilloni, C Scordato, et al.
International Journal of Obesity (2005)
|
February 13, 2013
Permanence of molecular features of obesity in subcutaneous adipose tissue of ex-obese subjects
R Cancello, A Zulian, D Gentilini, et al.
Journal of Molecular Endocrinology
|
December 1, 1995
A thyroid hormone receptor beta gene polymorphism associated with Graves' disease
V Tassi, L Scarnecchia, A Di Cerbo, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
October 18, 2000
Leptin plasma concentrations are dependent on body fat distribution in obese patients
A Minocci, G Savia, R Lucantoni, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1981
Size reduction of macroprolactinomas by bromocriptine or lisuride treatment
P Chiodini, A Liuzzi, R Cozzi, et al.
Journal of Endocrinological Investigation
|
April 9, 2002
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study
M Gasperi, E Martino, L Manetti, et al.
Page
of 13